MYH11 Antikörper
Kurzübersicht für MYH11 Antikörper (ABIN5707515)
Target
Alle MYH11 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified
-
Reinheit
- Protein A affinity chromatography
-
Immunogen
- Recombinant human protein was used as the immunogen for the recombinant SMMHC antibody.
-
Isotyp
- IgG kappa
-
-
-
-
Applikationshinweise
-
Optimal dilution of the recombinant SMMHC antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant SMMHC antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- MYH11 (Myosin Heavy Chain 11, Smooth Muscle (MYH11))
-
Andere Bezeichnung
- SMMHC (Smooth Muscle Myosin Heavy Chain)
-
Hintergrund
- Smooth muscle myosin heavy chain (SM-MHC) is a cytoplasmic structural protein, which is a major component of the contractile apparatus in smooth muscle cells. Expression of smooth muscle myosin is developmentally regulated, appearing early in smooth muscle development, and is specific for smooth muscle development. Two isoforms of smooth muscle myosin heavy chain have been identified, designated MHC-1 and MHC-2. The antibody may be useful for the study of breast tumors as the presence of an intact layer of myoepithelial cells is an important feature, which may distinguish benign breast lesions and carcinoma in situ from invasive tumors.
Target
-